Who Owns Pfizer?
Updated onExplore the ownership hierarchy of Pfizer. See parent companies, holding structures, and ultimate controllers.
Ownership Chain
Pfizer
Pfizer is an American multinational pharmaceutical and biotechnology company that discovers, develops, manufactures, and markets medicines and vaccines worldwide.
Pfizer appears to be independent with no known parent company.
Pfizer
Pfizer is an American multinational pharmaceutical and biotechnology company that discovers, develops, manufactures, and markets medicines and vaccines worldwide.
Pfizer appears to be independent with no known parent company.
Major Shareholders
Pfizer
Major Shareholders
| Name | Type | Ownership | Voting | As of |
|---|---|---|---|---|
Vanguard Group Inc. Largest shareholder; about 534M Pfizer shares reported in Q3 2025 13F filings, roughly 9.4% of shares outstanding. | Institutional | 9.4% | 9.4% | Sep 2025 |
BlackRock Inc. Second‑largest holder with just under 500M shares, for an approximate 8.7–8.8% stake as of Q3 2025 filings. | Institutional | 8.8% | 8.8% | Sep 2025 |
State Street Corp. Owns just under 300M shares, corresponding to roughly 5.3% of Pfizer as of the September 30, 2025 reporting period. | Institutional | 5.3% | 5.3% | Sep 2025 |
Geode Capital Management LLC Index‑oriented asset manager that holds about 129M shares, or roughly 2.3% of Pfizer. | Institutional | 2.3% | 2.3% | Sep 2025 |
Morgan Stanley Large U.S. financial institution with roughly 75M shares, or about 1.3% ownership. | Institutional | 1.3% | 1.3% | Sep 2025 |
Northern Trust Corp. Custody bank and asset manager holding about 64M shares, around 1.1% of Pfizer. | Institutional | 1.1% | 1.1% | Sep 2025 |
Wellington Management Group LLP Boston‑based active manager with roughly 60M shares, a little over 1.0% of the company. | Institutional | 1.1% | 1.1% | Sep 2025 |
Massachusetts Financial Services Co. (MFS) Global asset manager that reports holding about 57–58M shares, or ~1.0% ownership. | Institutional | 1.0% | 1.0% | Sep 2025 |
State Farm Mutual Automobile Insurance Co. Insurance group that beneficially owns roughly 55M shares, just under 1% of Pfizer. | Institutional | 1.0% | 1.0% | Sep 2025 |
Charles Schwab Investment Management Inc. Asset‑management arm of Charles Schwab, holding about 50M shares (~0.9%). | Institutional | 0.9% | 0.9% | Sep 2025 |
Other institutional & retail investors (combined) Beyond the largest holders listed above, Pfizer’s ownership is widely dispersed: institutional investors in total hold roughly mid‑60%s of shares, insiders around 0.1–0.3%, and the remaining ~30–35% is held by retail and other public investors. | Other | — | — | Sep 2025 |
Get Started
Your ultimate competitive playbook
You just found your top competitors. Now let's map your whole landscape and show you how to stand out.
Competitive Landscape Report
Built for small teams who can't hire a full-time analyst.
$129 $260 one-time payment
Generated in minutes, no subscription.
Instead of guessing what to do about your competitors, get a done-for-you intelligence report
Competitor Map
Direct, indirect, and alternative competitors mapped across your market
Positioning Analysis
How each competitor positions, their ICP, and key differentiators
Feature & Pricing Matrix
Side-by-side comparison of features, pricing, and packaging strategies
Growth Channel Analysis
SEO, paid ads, content, and social strategies across the landscape
Reputation & Social Proof
Ratings, reviews, and sentiment analysis across all competitors
90-Day Action Plan
Specific tactics to differentiate and win more deals in the next 3 months